TriangleNCT02002598 · OUTCOME
Time to Next Treatment (TTNT)
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- months
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- Up to 6.5 years
What was measured
The TTNT is measured from the date of initiation of treatment to the start date of the next treatment regimen.
Groups in this outcome
CFZ With Bendamustine and Dexamethasone
All participants who received at least two cycles of CFZ either at 27mg/m\^2, 36mg/m\^2, 45 mg/m\^2, or 56mg/m\^2.
| Group | Source count |
|---|---|
| CFZ With Bendamustine and Dexamethasone | 19 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| CFZ With Bendamustine and Dexamethasone | 77.0 | Not reported | 36.1 | NA | The upper limit is not applicable due an to insufficient number of participants with events. |
Complete source fields
- classes
- categories
- measurements
- comment
- The upper limit is not applicable due an to insufficient number of participants with events.
- group Id
- OG000
- lower Limit
- 36.1
- upper Limit
- NA
- value
- 77.0
- denoms
- counts
- group Id
- OG000
- value
- 19
- units
- Participants
- description
- The TTNT is measured from the date of initiation of treatment to the start date of the next treatment regimen.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- All participants who received at least two cycles of CFZ either at 27mg/m\^2, 36mg/m\^2, 45 mg/m\^2, or 56mg/m\^2.
- id
- OG000
- title
- CFZ With Bendamustine and Dexamethasone
- param Type
- MEDIAN
- reporting Status
- POSTED
- time Frame
- Up to 6.5 years
- title
- Time to Next Treatment (TTNT)
- type
- SECONDARY
- unit Of Measure
- months
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice